CISPLATIN

作品数：604被引量：1584H指数：17
导出分析报告
相关领域：医药卫生更多>>
相关作者：曾慧慧王夔卢仁泉郭林李强更多>>
相关机构：华中科技大学四川大学北京大学卫生部更多>>
相关期刊：更多>>
相关基金：国家自然科学基金中国博士后科学基金国家重点基础研究发展计划广东省自然科学基金更多>>
-
在结果中检索

检索结果分析

结果分析中...
选择条件：
  • 期刊=Journal of Cancer Therapyx
共 条 记 录，以下是1-10
全选清除导出
参考文献引证文献引用追踪
视图：
排序：
Salivary Gland Tumors: Randomized Study of Adjuvant Chemo-Radiotherapy versus Radiotherapy Alone
《Journal of Cancer Therapy》2021年第10期531-553,共23页Tarek Shouman Azza Niazy Taher Amany Helal Ahmed Charaf 
Objective: Concurrent chemoradiation value of the resected salivary tumor adjuvant context against regular radiation therapy alone.
关键词：Salivary gland Tumors CHEMORADIATION RADIOSENSITIZER CISPLATIN Adenoid Cystic Tumors MUCOEPIDERMOID 
Accelerated Hypofractionated Radiotherapy and Concurrent Etoposide/Cisplatin in Patients with Limited-Disease SCLC (LD-SCLC)
《Journal of Cancer Therapy》2020年第11期683-694,共12页Wessam Elghamry Ali Azmy Iman Fouad Zeinab Elsayed Sherif Abdelwahab 
Background: 
关键词：LD-SCLC ETOPOSIDE CISPLATIN Accelerated Radiation Therapy 
Therapeutic Outcomes of HPV Positive and HPV Negative Oropharyngeal Squamous Cell Carcinomas
《Journal of Cancer Therapy》2020年第9期507-518,共12页Aravindh Sivanandan Anand Gopika Presenavarman Salima Rema Windsor Priya Venugopaladas Saraswathy 
Background & Objectives: HPV associated (HPV+) oropharyngeal cancers, compared with HPV non-associated ones (HPV?
关键词：Oropharyngeal Squamous Cell Carcinoma HPV CHEMORADIATION DOCETAXEL CISPLATIN 5-FLUOROURACIL Treatment Response 
Combination Treatment with BEC and Cisplatin Synergistically Augments Anticancer Activity and Results in Increased Absolute Survival被引量：3
《Journal of Cancer Therapy》2020年第8期470-482,共13页B. E. Cham 
Plant-derived BEC with its main component solamargine possesses anticancer activities via its effect on a variety of biological pathways in a wide range of human cancer cells. High cure rates with BEC therapy have bee...
关键词：BEC SOLAMARGINE CISPLATIN Curaderm ANTI-CANCER 
New Insights into the Discovery of Novel Drugs to Treat Human Pulmonary Adenocarcinoma被引量：1
《Journal of Cancer Therapy》2019年第2期178-187,共10页Yu Wang Haishan Zhang Yingxin Chen Lining Wang 
Lung cancer is one of the most prevalent cancers in the world. A cisplatin-based chemotherapy regimen is commonly used to major patients who have adenocarcinoma. Because of the limited remission rate, many patients ne...
关键词：CISPLATIN DOCETAXEL PEMETREXED ADENOCARCINOMA In VITRO In Vivo Clinical Trial 
Prospective Analysis of Patients Treated with Chemotherapy in Metastatic Adenocarcinoma of Lung—Single Centre Experience
《Journal of Cancer Therapy》2017年第9期838-844,共7页B. J. Srinivasa L. P. Bhanu Girish Badarke Mohammad Nasiruddin Sulav Sapkota D. Tousif Vishal Kulkarni P. K. Kiran Vinu Sarathy G. S. Deepika Amritanshu Ram Raghavendra Rao Shekar Patil Radheshyam Naik 
Background: Lung cancer is the leading cause of cancer-related death worldwide with an estimated 1.6 million new cases diagnosed each year. According to standard guidelines in NSCLC, the effectiveness of combined chem...
关键词：PEMETREXED CARBOPLATIN NSCLC CISPLATIN EGFR 
High Response Rate to Second-Line Combination Antiangiogenic Chemotherapy in Patients with Metastatic Melanoma
《Journal of Cancer Therapy》2016年第12期908-918,共12页Ozan Haase Ozan Angün Ewan A. Langan Franziska Hübner Florian M. Vogt Christoph Thorns Detlef Zillikens Patrick Terheyden 
Objectives: Despite the array of new treatment strategies for the management of metastatic melanoma, the prognosis remains poor when immune checkpoint inhibition and targeted therapy options are exhausted. The antiang...
关键词：MELANOMA CISPLATIN CARBOPLATIN BEVACIZUMAB Response Angiogenesis 
The Outcome of Treatment for Patients with Borrmann Type 4 Advanced Gastric Cancer
《Journal of Cancer Therapy》2016年第12期953-962,共10页Rie Tamaki Fumio Amano Tohru Hashida Hironaga Satake Hisateru Yasui Akihito Tsuji 
Introduction: The survival rate of patients with Borrmann type 4 advanced gastric cancer is extremely poor in comparison to patients with gastric cancers of other histological types. An optimal chemotherapeutic regime...
关键词：Gastric Cancer ADENOCARCINOMA Scirrhous CISPLATIN Chemotherapy METASTASIS 
Final Results of a Phase II Study of Bevacizumab, Cisplatin and Pemetrexed as First-Line Therapy for Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer
《Journal of Cancer Therapy》2016年第7期455-463,共9页Guillermo López Vivanco Eider Azkona Sergio Carrera Aintzane Sancho Itziar Rubio Juan Manuel Mañé Begoña Calvo Unai Aresti Aitziber Buque Inés Marrodán Alberto Muñoz 
Background: Efficacy and safety data for cisplatin and pemetrexed plus bevacizumabinnon squamousnon non-small cell lung cancer (NSCLC) are still limited. Nevertheless, either bevacizumab plus platinum doublet or pemet...
关键词：Non-Small-Cell Lung Cancer BEVACIZUMAB PEMETREXED Predictive Biomarker KRAS 
The Effect of Fullerenol Combined with Cisplatin on the Proliferation of Cervical Cancer HeLa Cells
《Journal of Cancer Therapy》2016年第3期232-238,共7页Yuan Niu Chao Yan 
This study aimed to investigate the effect of fullerenol combined with cisplatin on the proliferation of cervical cancer HeLa cells in order to provide new ideas and laboratory theoretical basis for the clinical treat...
关键词：FULLERENOL CISPLATIN HeLa Cells PROLIFERATION APOPTOSIS 
全选清除导出
共3页<123>
检索报告 对象比较 聚类工具 使用帮助 返回顶部